Literature DB >> 2076732

Yohimbine increases salivary secretion in depressed patients treated with tricyclic antidepressants.

Y Rispail, L Schmitt, M Berlan, J L Montastruc, P Montastruc.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076732     DOI: 10.1007/BF00315426

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Yohimbine increases human salivary secretion.

Authors:  E Chatelut; Y Rispail; M Berlan; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

Review 2.  New subtypes of muscarinic acetylcholine receptors.

Authors:  T I Bonner
Journal:  Trends Pharmacol Sci       Date:  1989-12       Impact factor: 14.819

3.  Effects of yohimbine on submaxillary salivation in dogs.

Authors:  P Montastruc; M Berlan; J L Montastruc
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

4.  Anticholinergic activity of two tricyclic antidepressants.

Authors:  B Blackwell; A Stefopoulos; P Enders; R Kuzma; A Adolphe
Journal:  Am J Psychiatry       Date:  1978-06       Impact factor: 18.112

  4 in total
  3 in total

1.  Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants.

Authors:  H Bagheri; L Schmitt; M Berlan; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

2.  Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine.

Authors:  M Berlan; R Le Verge; J Galitzky; P Le Corre
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

3.  Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.

Authors:  H Bagheri; P Picault; L Schmitt; G Houin; M Berlan; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.